Directory · SG
Biotechnology Research in Singapore
A register of firms and the professionals working at them in the Biotechnology Research sector based in Singapore. Browse the public index, then filter or export on Kipplo.
Companies
260 on file
Mmr Consulting
MMR Consulting Inc. and its dedicated team of experienced consultants are committed to delivering high quality, robust solutions for the Pharmaceutical and Biotechnology industries. Our expertise includes Engineering (Process, Automation, Facilities), Capital Project Management of large/complex projects and programs, Commissioning Qualification Validation, and GMP Compliance services.
51 to 200 staff
Lucence
Lucence is a precision health company, using proprietary AI-powered liquid biopsy technology to detect cancers earlier when outcomes are better. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit
51 to 200 staff
A Star Institute Of Molecular And Cell Biology A Star Imcb
The Institute of Molecular and Cell Biology (IMCB) is a premier research institute at A*STAR whose mission is to harness biology for transformational bio-therapeutics and diagnostics. With a strong emphasis on collaboration with stakeholders across the ecosystem in Singapore, IMCB aims to achieve scientific excellence and continues to nurture the next generation of scientists in order to create growth and enhance lives.
201 to 500 staff
Syaqua
Founded in 2001, SyAqua Group, cemented its position as a strong emerging player in commercial shrimp genetics market. Further solidifying SyAqua’s market presence was the acquisition by Gold Coin in 2011 as an independent entity for Gold Coin's hatchery feed operations. In 2022, Ocean 14 Capital obtained a majority share, marking a significant turning point in SyAqua's trajectory to pioneer sustainable shrimp technologies in both genetics and nutritional feed. SyAqua Genetics division has gained significant traction in major Global markets, such as USA, China, India, Indonesia, Thailand, and Malaysia. SyAqua's renowned Balanced Line genetics, is a combination of robustness, higher survival rate, and excellent growth, has excelled across diverse production environments and management systems in Asia. To maintain a competitive edge, SyAqua continues to consistently invest in cutting-edge genetics research and industry experts to ensure a consistent delivery of improved performance. Recently, SyAqua Nutrition inaugurated a state-of-the-art hatchery feed plant, equipped with best-in-class technology, to broaden its range of feeds, thereby fortifying its presence in pivotal markets. This strategic move aims to strengthen SyAqua's position as a major player in hatchery solutions and a leading provider of high-quality early nutrition for shrimp. SyAqua’s robust presence in key markets, is grounded through successful long-term customer relationships accompanied by unrivalled customer service. With a combined management team with over 200 years of collective experience in aquaculture, nutrition, and genetic solutions, SyAqua, dedicates this wealth of expertise to support the thriving success of hatcheries and farms, globally. Together with O14C, SyAqua will pioneer the shrimp industry, creating sustainable shrimp technologies, addressing the needs of shrimp farming today, and ensuring sustainable food security for tomorrow.
201 to 500 staff
Amili
AMILI is the #1 precision gut microbiome company in Southeast Asia, based in Singapore. AMILI hosts Southeast Asia’s first and only gut microbiome transplant bank and the world’s largest multi-ethnic Asian gut microbiome database. Our precision-driven, end-to-end platform captures unparalleled insights into gut microbiome abundance, functionality, and its impact on health. For more information, visit
11 to 50 staff
Mirxes
Mirxes is a Singapore-headquartered biotechnology company whose mission is to save lives through early, actionable, and personalized diagnoses across the care continuum. We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. We have sales and distribution networks worldwide. Our flagship product is GASTROClear, the world’s first molecular blood test for early detection of gastric cancer, able to detect around 90% of patients with Stage I and II cancers. We continue to build a comprehensive cancer portfolio with early detection tests for lung and thyroid cancer (2022), colorectal and breast cancer (2023), liver and ovarian cancer (2024). We are concurrently building a precision oncology portfolio to provide clinical insights for the complete patient journey. MiRXES was spun off from A*STAR’s Bioprocessing Technology Institute in 2014 to commercialize an industry-leading qPCR-based technology for microRNA detection. Our ID3EAL discovery tool and workflow has been adopted by top academic and industry partners globally and is backed by the world’s first industry standard for microRNA-base diagnostics. Our versatile platform technology and capabilities have broad applications in the discovery of biomarkers and diagnosis of diseases. We are starting with early cancer detection, but we will also be addressing unmet clinical needs in cardiovascular, metabolic, and infectious diseases. We responded to COVID-19 by leveraging our capabilities to mass produce and distribute over 5 million units of the Fortitude COVID-19 RT-PCR test. This made-in-Singapore diagnostic test, developed by A*STAR and Tan Tock Seng Hospital, has been deployed in 13 Singapore hospitals and clinical labs and exported to over 45 countries worldwide. Post-COVID, we will leverage this network to commercialize multi-cancer early detection tests.
201 to 500 staff
Cisbay
Cisbay is a bioinnovation company that provides a platform of agricultural products and environmental water treatment solutions globally. Founded in the Silicon Valley, Cisbay embarks on a new global transformation dedicated to restoring soil health and solving the global water crisis. Collaborating with scientists and researchers from several universities and research centers around the world, Cisbay delivers breakthrough technologies which will enhance food supply and precious water resources for future generations. Our mission is to empower farmers to achieve higher yield and cleaner waterways to maximize productivity and profitability through bio-innovative microbial solutions. CISBAY - Bioinnovation for Soil and Water
11 to 50 staff
Cordlife Group Limited
Cordlife owns the largest network of cord blood banks in Asia with full stem cell banking facilities in six key markets, namely Singapore, Hong Kong, Indonesia, India, Malaysia and the Philippines. In Singapore, Hong Kong, the Philippines and Indonesia, Cordlife operates the largest private cord blood banks and it is amongst the top three market leaders in India and Malaysia. In January 2018, Cordlife became the market leader in Hong Kong with the acquisition of the largest private cord blood bank, Healthbaby Biotech (Hong Kong) Co, Limited. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife has also established its presence in Myanmar, Vietnam, Macau, Brunei and Bangladesh.
501 to 1000 staff
Allozymes
Allozymes is a biotechnology company redefining enzyme engineering through its proprietary ultra-high-throughput microfluidic and AI-driven screening platform. By integrating biocatalysis, enzyme discovery, and microfluidic innovation, we accelerate the development of tailored enzymes for biomanufacturing, pharma, and life sciences. With a vision to build the world’s most comprehensive enzyme data library, Allozymes is enabling faster discovery, smarter optimization, and sustainable production across industries.
11 to 50 staff
Joil Singapore Pte Ltd
JOil Singapore is the world’s only commercial producer of Jatropha for the production of sustainable aviation fuel and other by-products that fuel the bioeconomy. JOil’s plantations in Ghana are a continuous, non-food source of Jatropha nuts for the production of biofuel, bioresin, biochar, bio-briquettes, bio compost etc. JOil holds 5 Patents with Gold Standard and ISCC certifications for its nucleus plantations. JOil has also established a tried and tested model of an outgrowers' program. With nucleus plantations and the outgrower program, JOil ensures a continuous, non-food source supply of Jatropha for the bio-economy. The company strives to mitigate carbon footprint and positively impact the livelihoods of communities through a scientific approach to establishing a Jatropha value chain – from cultivation to downstream applications. The company has established plantations in Ghana, Africa using regenerative agriculture on degraded land with pioneering high-yield Jatropha seeds. JOil addresses very relevant problems facing people and the planet through a pioneering Jatropha value chain and is present in regions with poor capacity and infrastructure. Climate change – Jatropha plantations remove carbon. Jatropha plants, stem and roots sequester carbon for 30 years. Land use & productivity – Jatropha grows on degraded lands and the cultivation of the plant is considered as reforestation. Jatropha is a non-edible feedstock for bio-substitutes and does not disrupt the food chain. Income generation – JOil provides a reliable source of income through employment opportunities for communities in the plantations. Safe and green products – The application of Jatropha for bio substitutes is eco-friendly and uses fewer raw materials in the by-products. Jatropha as feedstock for sustainable aviation fuel helps meet net zero emission targets.
501 to 1000 staff
Profileprint - Ai-Driven Ingredient Quality Platform
ProfilePrint helps global agri-food businesses buy, manufacture and sell better with our patented AI fingerprint technology. By capturing the molecular signature of samples, insights are generated in seconds, enabling stakeholders across the supply chain to make faster and more confident decisions on quality. Based in Singapore, we serve over 60 locations globally and are backed by global VCs and some of the world's largest food companies including Cargill, Louis Dreyfus Company, Olam, Sucafina and Sinar Mas.
11 to 50 staff
Rwdc Industries
RWDC Industries is on a mission to replace petroleum-derived materials with safe, sustainable alternatives. We have developed technology to harvest outputs of a microbial fermentation process using plant-based oils that produces a naturally occurring biodegradable polymer called PHA (or polyhydroxylalkanoate). PHA’s are biopolymers naturally produced by microbial fermentation of plant-based oils or sugar. RWDC’s PHA — Solon — is certified by TÜV Austria to be fully biodegradable in soil, water and marine conditions. Solon is 100% biodegradable with no toxic residue. Solon is a global solution to today’s plastic waste management challenge, and it's an ideal material for replacing petroleum-derived, single-use plastics — such as cutlery, cups, bags, plates and bowls. Solon safely biodegrades in natural environments, leaving absolutely no harmful remains or byproducts.
51 to 200 staff
Auristone Pte Ltd
Auristone is an Asian-based epigenomic profiling company powered with data analytics capabilities and extensive epigenomic know-how. We use our comprehensive portfolio of Asian epigenomic database to power data-driven drug and biomarker discoveries. EPI-Call™ is our Flagship second generation Next Generation Sequencing (NGS) test. In addition to genomic information (DNA-seq), EPI-Call™ further provides epigenomic information around the tumour micro-environment and predicts patient response to immunotherapy. EPI-Call™ is the pragmatic choice to aid physicians in deciding the best treatment option for their patients. We are committed to supporting clinical and academic epigenomic research, and moving such research outcomes into the clinical setting. Driven by our aspiration to improve the quality of life for patients through better treatment, we are continuously seeking ways to bring our technologies to our clinical and academic partners. For more information on the company, drop us a line at enquiry@auristone.com or visit our website at
1 to 10 staff
Biomax Green Pte Ltd
Biomax Green is a leading biotechnology company built on a fundamental belief that the world is our community and we have the responsibility to put the needs of our people, communities and the environment first. After years of intensive research, we successfully revolutionised the global organic waste treatment industry with our innovative breakthrough technology. Characterised by a relentless pursuit of innovation, quality, and safety and beyond all things organic, we continue to be at the forefront of creating a sustainable and green ecosystem both locally and internationally.
11 to 50 staff
Cellresearch Corporation
CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. In 2004, our scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date we have patents granted in multiple strategic key territories around the world. The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy. Considerable headway has already been achieved, and we have started USFDA Clinical Trials with our collaborators in the USA, leading to a therapy to accelerate wound healing.
11 to 50 staff
Cordlife Singapore
Listed on the Main Board of the Singapore Exchange ("SGX"), Cordlife Group Limited ("Cordlife", and together with its subsidiaries, the "Group") is presently a service provider of umbilical cord blood and cord lining banking. The first cord blood bank to be set up in Singapore (May 2001) and amongst the first in Asia, Cordlife Group Limited has more than 16 years of cord blood banking experience as well as a published track record of cord blood transplants. The Group currently owns and operates full processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines. Cordlife's processing and storage facilities in Singapore, Hong Kong and India are AABB accredited and by late 2015, the Singapore facility achieved accreditation from FACT-Netcord, placing the Group as one of the six international private cord blood banks that hold accreditations by two world-class standards. Besides being the first private cord blood bank in Southeast Asia to enjoy the dual-accreditation status, the Group also extends its products and services to families in the region through its associate in Thailand and sub-licensing partner in China.*Conditional accreditation status for Cordlife’s facility in Singapore
51 to 200 staff
Cryoviva Singapore
Established in early 2014, Cryoviva Singapore has successfully stored many samples of local and expat clients, and is managed and maintained by a team of experts. We have an extensive list of happy parents who have trusted our services and stored their baby’s cord blood with us. As a group, Cryoviva has more than cord blood units successfully stored in our regional facilities. Cryoviva affiliated companies have well established and highly accredited operations in umbilical cord stem cell banking in India and Thailand. In Singapore, we have our own MoH licensed laboratory that demonstrates stringent processes and high-quality standards to ensure each sample is handled and processed with utmost care. Our Singapore facility is very centrally located, so it requires even lesser time for the sample to reach our labs from most maternity hospitals.
51 to 200 staff
Dotbio
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit
1 to 10 staff
Ecolex Animal Nutrition
Founded in 2005, Ecolex Animal Nutrition is a global leader in innovative animal nutrition, with expertise embedded in molecular engineering and bioscience. We are dedicated to developing sustainable solutions that enhance productivity while minimizing environmental impact. Ecolex has become established as a leading manufacturer and supplier of specialty rumen bypass and rumen inert fats for the global dairy farming business. From our state-of-the-art production facility near Port Klang, Malaysia, we serve an extensive export market, supplying to more than 35 countries across five continents. Today, our core expertise is focused in 3 key areas: • Emulsification Technologies: We lead the industry in advanced emulsification techniques that improve nutrient bioavailability and feed efficiency. • Advanced Lipid Nutrition: Our specialists develop optimized fatty acid balances to enhance animal health and performance. • Sustainable Insect Proteins: We pioneer the production of alternative protein sources that support eco-friendly practices.
201 to 500 staff
Esco
Esco Lifesciences Group is a world-leading manufacturer of laboratory, pharmaceutical equipment, bioprocess tools and IVF medical devices, delivering sustainable workflow solutions to advance global health. Since 1978, the Singapore-based company is committed to excellence, ensuring forward-thinking technology, responsive support, and reliability, making Esco a trusted partner for the life science and medical markets in more than 150 countries. Our Vision Strategically positioned to bridge the East and West, Esco aspires to become the leading provider of life science and fertility tools, delivering sustainable technologies that foster a healthier, more equitable, and resilient future. Our Mission We provide cutting-edge, sustainable workflow solutions that empower scientists and innovators to advance global health and enhance quality of life. ROOTED IN VALUES; DRIVEN BY SUCCESS
1001 to 5000 staff
Atlantis Bioscience Pte Ltd
Atlantis Bioscience Pte Ltd is a Singapore-based manufacturer and distributor of cell culture reagents and lab equipment started in 2016. We take pride in our transparent and customer-oriented work culture. Our team is not bounded by the archaic rules to be at a desk. The best ideas may not even come in an office. Our customers and partners require swift service and solutions. As such, we strive to incorporate cloud solutions and equip our team with the latest technologies to help customers across several markets. Our mission is to facilitate global customers access to good products or technologies which may be unknown to them. Singapore is geographically well placed for us to help our partners in a very short turnaround time in Asia.
1 to 10 staff
Biocon Solutions Pte Ltd
About Us- Biocon Solutions is a Singapore headquartered company which was started in 2004. We are pharma engineers partnering with leading containment specialist to provide an integrated solution for pharma and life science industries. We have our offices in India, Indonesia, Malaysia and Thailand. The USP of Biocon is the strength of our technical team wherein we provide the installation and qualification for the equipments we supply. It is our endeavor to strive hard to bring the best of our solutions, cost effective to our clients that has made us successful in this competitive market. Vision – 1. To become a leading pharma service provider in the global life science market. Continuously improving through technology upgradation and employee training. Mission- 1. We are committed to provide high quality engineering services to exceed customer satisfaction. To make a positive contribution to the world by delivering environment friendly services/products.
11 to 50 staff
Cerecin
Cerecin is a global healthcare company with more than 20 years of innovation and leadership in brain health. At Cerecin we think differently. We develop novel evidence-based solutions that help people; pharmaceuticals, medical foods, diagnostics, medical devices and e-health products. These solutions target conditions ranging from memory impairment to some of the most devastating neurological diseases.
11 to 50 staff
Deltafrontier
DeltaFrontier PTE LTD (“DF”), a Singapore based value added solution company; In this Era of globalization, when technologies evolve rapidly.Deltafrontier is strategically well-positioned to lead at the forefront of cutting-edge AIoT technologies. With Deltafrontier, you can expect reduced execution cost, proven risk mitigation strategies and industry-specific technical advice with wide sourcing excellence.
1 to 10 staff
Engine Biosciences
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications. In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
11 to 50 staff
Guardant Health Amea
Guardant Health AMEA is a wholly owned subsidiary of Guardant Health, a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening with Shield™ to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer.
11 to 50 staff
N&e Innovations Pte Ltd
Our mission is to solve the world’s toughest problems using all natural solutions that are sustainable, safe for the environment and our health. We are a BioTech company that pioneered our groundbreaking patented technology called ViKANG that is transforming the areas of Food, Medical, Hygiene and Plastics. ViKANG is a potent antimicrobial additive that is Green Label Certified, non-toxic and long lasting, with zero toxic chemicals or heavy metals usage. ViKANG is extremely versatile in its use case as a coating or embedded technology. Our recent Food Packaging plastics are engineered to be 99.9% antibacterial which drastically reduce food poisoning risks, extend the shelf life of fresh produce, thereby cutting CO2 emissions of food spoilage.
11 to 50 staff
Scg Cell Therapy
Established and headquartered in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a leading biotechnology company that combines regional advantages in Singapore, China and Germany, to cover the entire value chain from innovative drug research and discovery, manufacturing, clinical development and commercialization. SCG specializes in the development of novel immunotherapies in infections and its associated cancers. The company targets the most common cancer-causing infections: helicobacter pylori, human papillomavirus, and hepatitis B, and develops a broad and unique pipeline of T cell therapies, antibodies, and therapeutic vaccines against infections and to prevent and cure its associated cancers. SCG collaborates with leading scientists and researchers to bring first-in-class medical products/technologies to enhance innovation in medical product development.
51 to 200 staff
Traque Pte Ltd
Traque specialises in the provision of Training, Regulatory compliance, Auditing, Qualification and Equipment supply, installation, commissioning, service and maintenance to the Life Science and related industries. We work with some of the worlds largest suppliers of process and related equipment to provide total process solutions. Our years of hands on experience ensure that we can install, commission, validate and support any equipment which we supply.
11 to 50 staff
Turtletree
At TurtleTree, we are pioneering the future of health with our breakthrough product, LF+: the world’s first vegan lactoferrin created through cutting-edge precision fermentation technology. Lactoferrin, a bioactive milk protein, enhances the nutritional profile of a wide range of food and health products. From plant-based alternatives and traditional foods to skincare and cosmetics, LF+ provides exceptional health benefits. Our innovative process not only contributes to human health but also ensures that animals can live carefree, happier lives. As we continue to push the boundaries of food science, we are seeking out partners and investors to join us as we create a healthy and sustainable future. Join the health revolution. Where Nutrition Meets Humanity.
11 to 50 staff
Impacfat
Impacfat is enticing a larger demand for sustainable food choices. We have created cell-based fish fat that is nutrition-customisable. This means tastier, wholesome plant-based and cultivated meats. With the absence of antibiotics and GMOs, our fish fat is undeniably one of the safer alternatives in the market. As the founders say it best: “Fat that you want to gain!”
1 to 10 staff
Tessa Therapeutics Ltd
Tessa Therapeutics is a clinical-stage biotechnology company developing next-generation cell therapies for the treatment of hematological cancers and solid tumors. Tessa’s autologous CD30-CAR-T therapy TT11, is currently being investigated as a potential treatment for relapsed or refractory classical Hodgkin lymphoma as both a monotherapy (Phase 2) and combination therapy (Phase 1b). TT11 has been granted RMAT designation by the FDA and access to the PRIME scheme by European Medicine Agency. Tessa is also advancing an allogeneic “off-the-shelf” cell therapy platform targeting a broad range of cancers in which Epstein Barr Virus Specific T Cells (EBVSTs) are augmented with CD30-CAR. This platform is currently the subject of a Phase 1 clinical trial in CD30-positive lymphomas. Tessa has its global headquarters in Singapore, where the company has built a state-of-the-art, commercial cell therapy manufacturing facility. For more information on Tessa, visit
51 to 200 staff
Ants Innovate
Ants Innovate is a deep tech start-up focusing on developing cultivated whole meat cuts. Our mission is to create real meat without the environmental impacts and animal harm. Using our proprietary biotechnologies, we recreate the natural processes of muscle growth, developing delicious, textured meat with precision. Our meat cuts will be healthier and better for the world, and everyone in it.
1 to 10 staff
Bioacumen Global Pte Ltd
BioAcumen Global manufactures and supplies life science research and diagnostic products, made in Singapore. We are the official partner of Biomeme Inc, providing mobile solutions for COVID-19 real-time PCR tests. We are also distributors of Hanil Scientific Inc. for laboratory equipment as well as Genolution Inc. for automated DNA/RNA extraction solutions. We offer labelling solutions as a distributor of LabTAG by GA International.
1 to 10 staff
Biocheetah Pte Ltd
BioCheetah is a Singapore-based, Agency Science Technology and Research(A*STAR)-Institute of Molecular and Cell Biology(IMCB) spin-off company. It is primarily set up to develop and commercialize non-invasive, protein-based immunodiagnostic applications. First diagnostic applications in development are based on the proprietary bladder cancer biomarkers and detection antibodies discovered and developed in IMCB by BioCheetah’s Scientific Founder (Prof. Jean-Paul Thiery) and the co-Founder/Chief Executive Officer (Dr. Kian-Chung Lee). Products to be developed include professional use in-vitro diagnostic ELISA and Point-of-care test (POCT) kits. The kits will employ a novel multiplex urine-based biomarkers panel with high sensitivity and specificity for diagnosis and monitoring of bladder cancer. There are several clinical trials for clinical validation of the bladder cancer diagnostic products is currently underway locally and with several hospitals worldwide.
1 to 10 staff
Chitose Group
CHITOSE Group is a family of biotechnology companies leading the global bioeconomy. Our vision is to enable humanity to live in abundance for the next millennium by harnessing the power of living things. Through both technological innovation and business development, we collaborate with partners worldwide to unlock the potential of biotechnology. MATSURI INITIATIVE MATSURI began in 2021 with the goal of building a microalgae industry. From 2025 onward, it has evolved beyond microalgae, transforming into a cross-industry initiative that drives the bioeconomy, striving to build a bio-based society. https://matsuri-partners.chitose-bio.com/en STABLE CELL LINE DEVELOPMENT SERVICE Chitose Laboratory accelerates biopharmaceutical development and reduces costs using its high-performance CHO-MK cells to support global healthcare. https://chitose-bio.com/cld-service AI x BIOMANUFACTURING Chitose Laboratory is developing a bio-production management system that achieves advanced culture control beyond human capability. By integrating sensing technologies that convert subtle changes into measurable data with AI-driven prediction and optimization, we are realizing a new frontier of biomanufacturing. https://chitose-bio.com/jp/ai-bioproduction (Japanese) CHITOSE AGRICULTURE Chitose Agriculture promotes sustainable farming that provides tasty crops for a thousand years by emphasizing a healthy soil environment. https://agriculture.chitose-bio.com/en
201 to 500 staff
Entobel
Entobel is converting low value organic substrate into high quality products thanks to insects. Our main current products are sustainable animal feed (proteins and oils) and organic fertilizer. Since 2013, Entobel is running a commercial scale production site in Vietnam and exporting products worldwide. Entobel complies with highest standards in the industry (ISO only use tracable feedstocks and is FDA approved. Entobel is looking for strong partners to join for its expansion plans. Don't hesitate to contact us for more information.
51 to 200 staff
Igene Laboratory
iGene Laboratory is a clinical laboratory licensed by Singapore Ministry of Health (MOH) and accredited by the College of American Pathologists (CAP) in Next Generation Sequencing (NGS) and Molecular Microbiology including COVID-19 testing services. iGene Laboratory also subscribes to GenQA and QCMD standards.
51 to 200 staff
Kyan Technologies
KYAN Technologies, a pioneering leader in the field of precision medicine for oncology. Our company is dedicated to revolutionizing cancer care by leveraging cutting-edge technology and expertise. At KYAN, we have developed Optim.AI, a state-of-the-art Functional Precision Medicine test. This powerful tool empowers oncologists by providing them with critical insights to make informed clinical decisions for their patients. Our core mission is to bridge the existing gap in cancer care, and we achieve this through our unique specialization in integrating small data AI and biological experiments. Through our proprietary platform, we offer an efficient solution that transforms the identification of optimal outcomes from vast drug-dose combinations, revolutionizing the development and delivery of therapies to patients. In addition to our groundbreaking technology, KYAN is committed to conducting extensive research studies across various cancer indications, including Colorectal and Breast Cancer. These studies not only contribute to the advancement of biopharma services but also aid in the development of novel biopharmaceutical assets.
1 to 10 staff
Macrogen Asia Pacific Pte. Ltd
Macrogen APAC is a wholly owned subsidiary of Macrogen, Inc.(KOSDAQ: 038290), a precision medicine biotechnology company headquartered in Korea. Macrogen APAC has a cutting edge laboratory in Biopolis, Singapore, providing NGS and CES services. The facility is able to analyse human genomes per year. Our location in Singapore enables us to increase the level of service to our customers residing in Singapore, and neighbouring countries in South-east Asia.
11 to 50 staff
Novogeneait Genomics
NovogeneAIT Genomics, headquartered in Singapore, is a premier provider of multi-omics services and solutions. Established in 2016 through a strategic joint venture between Novogene and AITbiotech, we have grown to be one of the largest NGS service providers in Southeast Asia. Our unwavering commitment to delivering high-quality, efficient, and cost-effective omics solutions has propelled us to the forefront of genomic research. NovogeneAIT Genomics offers an extensive range of multi-omics services, including genomics, transcriptomics, single-cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our cutting-edge sequencing center in Singapore, we are dedicated to advancing scientific research by providing superior data quality. For more information, visit
1001 to 5000 staff
Peptobiotics
Livestock disease prevention and sustainable agri productivity. Singaporean synbio startup funded by EF Venture Capital.
1 to 10 staff
Probi Ab
Probi® is a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food. Founded on science, and together with customers and research partners, Probi is striving towards a future in which as many people as possible can take control of their gut microbiome - so that they can live better lives for longer. Born out of Lund University in Sweden in 1991, Probi has grown to serve over 40 markets worldwide and holds multiple patents globally. Probi is part of @Symrise AG, further strengthening capabilities and global reach. As such, Probi leverages this combined strength to advance future-ready solutions in health and well-being. Discover more on and
51 to 200 staff
Tikva Allocell Pte Ltd
Tikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.
11 to 50 staff
Vectura Fertin Pharma Laboratories
At Vectura Fertin Pharma Laboratories, your research goals are our priority. Vectura Fertin Pharma Laboratories is a GLP-compliant and accredited, preclinical CRO based in Singapore. We offer a range of preclinical services, from GLP toxicology safety assessments, aerosol generation and delivery to research support services to help you achieve your research goals. With over 10 years of research experience with specialisation in inhalation toxicology and aerosol sciences, we are in a unique position to offer all our clients a diverse repertoire of highly customisable preclinical services. Our experience, science, and core values govern what we do, and companies can count on our steadfast commitment to quality research and our promise to deliver. Our Mission: To accelerate drug development by providing data-driven science to all our clients and confidently achieve regulatory approval and sustainable growth. Our Vision: To be the preferred solution provider in preclinical research with a global reputation in improving human health through science and innovation. Our Core Values: Quality, Innovation, Integrity, Client Focus
51 to 200 staff
Aitbiotech
Established in Singapore since 2006, AITbiotech Pte Ltd is an ISO 13485 certified biotechnology company that develop, manufacture and supply Singapore-branded molecular diagnostic and genomic products for the international market. Its products are now sold in more than a dozen Asian countries. Apart from having a core team of experienced biotechnologists for in-house development, AITbiotech also works very closely with local scientific and medical experts such as A*STAR and NUS. AITbiotech is the first Southeast Asian Company to commercialize multiplex real-time PCR assays under the brand abTES™ for the detection of pathogens such as Influenza, Dengue, Chikungunya, Zika and Malaria. As part of the company’s vision to provide a complete portfolio for molecular diagnostic solutions, it has its own range of instrumentation for nucleic acid extraction, PCR and real-time PCR, as well as their accompanying reagent and consumables. It is also the distributor of other life science products in Singapore including Eppendorf and New England Biolabs instrument and reagents.
11 to 50 staff
Avecris
At Avecris, we are developing an innovative genetic vector platform technology that will enable a new class of medicines. Our technology is: Universally programmable Scalable Redosable Non-integrating Cell-type specific Low cost
1 to 10 staff
Biocomm Pte Ltd
From Concept To Marketplace. You focus on what you do best, we will do the rest. Founded in 1994, Biocomm is your proven partner for fully integrated manufacturing solutions and customized formulations, ranging from liquids to lotions to creams. Offering access to industry leaders, state-of-the-art technologies and the best cutting-edge active ingredients, Biocomm® provides clients with fully integrated research and development, and CGMP-certified manufacturing capabilities that ensure effective, innovative and relevant products. Harnessing the best active ingredients and technologies, and our expertise in product formulation and development, Biocomm has been successful in helping clients and partners build strong brands and well-received bespoke products that make a difference in the marketplace. To date, our clients’ brands and products can be found in independent and chain retail outlets like pharmacies, personal care stores, supermarkets, convenience stores, hypermarkets, hospitals, government institutions, dental and medical clinics, cosmetic houses, and many other places across Asia. Essentially, Biocomm offers concept to marketplace capabilities. You focus on what you do best, we will do the rest.
11 to 50 staff
